Oligodendrogenesis and myelinogenesis during postnatal development effect of glatiramer acetate

  title={Oligodendrogenesis and myelinogenesis during postnatal development effect of glatiramer acetate},
  author={Renana From and Raya Eilam and Dekel D. Bar-Lev and Smadar Levin-Zaidman and Michael M. Tsoory and Patrizia LoPresti and Michael N. Sela and Ruth Soul{\'e} Arnon and Rina Aharoni},
Myelinogenesis in the mammal nervous system occurs predominantly postnatally. Glatiramer acetate (GA), a drug for the treatment for multiple sclerosis (MS), has been shown to induce immunomodulation and neuroprotection in the inflamed CNS in MS and in experimental autoimmune encephalomyelitis (EAE). Here we investigated whether GA can affect myelinogenesis and oligodendrogenesis in the developing nervous system under nonpathological conditions. Towards this end we studied myelination in mice… 

Combination Therapy With Fingolimod and Neural Stem Cells Promotes Functional Myelination in vivo Through a Non-immunomodulatory Mechanism

The results showed that FTY720 drives NSCs to differentiate into oligodendrocytes and promotes myelination in an ex vivo brain slice culture model, and in the developing CNS of healthy postnatal mice in vivo.

Role of Oligodendrocyte Dysfunction in Demyelination, Remyelination and Neurodegeneration in Multiple Sclerosis.

  • A. Dulamea
  • Biology, Psychology
    Advances in experimental medicine and biology
  • 2017
Evidence is presented about the potential therapeutic targets in re-myelination processes that can be accessed in order to develop regenerative therapies for MS and the different pathways leading to OLs and myelin loss in MS, as well as principles involved in restoration of myelin sheaths.

Baicalin Promotes CNS Remyelination via PPARγ Signal Pathway

It is found that baicalin (BA), a natural flavonoid, in addition to its well-known antiinflammatory effects, directly stimulates OLG maturation and CNS myelin repair and BA is an effective natural product for the treatment of demyelinating diseases.

The story of glatiramer acetate (copaxone) in the treatment of multiple sclerosis - the potential for neuroprotection by immunomodulatory treatment

Using the animal model of MS -experimental autoimmune encephalomyelitis (EAE), the mechanism of action of GA was elucidated and combined findings indicate that immunomodulatory treatment can counteract the neurode-generative disease course, supporting linkage between Immunomodulation, neuroprotection and therapeutic activity in the CNS.

Ulk4 deficiency leads to hypomyelination in mice

It is reported that Ulk4 acts as a key regulator of myelination, and ULK4 may therefore become a novel therapeutic target for hypomyelination diseases.

The benefits of neuroinflammation for the repair of the injured central nervous system

The benefits of neuroinflammation in fostering CNS recovery after neural injury using examples from multiple sclerosis, traumatic spinal cord injury, stroke, and Alzheimer’s disease are highlighted, and on CNS regenerative responses, such as neurogenesis, axonal regeneration, and remyelination are discussed.

Assessing remyelination - metabolic labeling of myelin in an animal model of multiple sclerosis

Remyelination in multiple sclerosis: realizing a long-standing challenge

  • R. Aharoni
  • Biology
    Expert review of neurotherapeutics
  • 2015
Cumulative findings indicate that immunomodulatory treatments can induce neuroprotective outcomes and provide a supportive milieu for repair processes in multiple sclerosis.



Promoting oligodendrogenesis and myelin repair using the multiple sclerosis medication glatiramer acetate

Results indicate that GA promotes oligodendrogenesis and remyelination through mechanisms that involve the elevation of growth factors conducive for repair.

Glatiramer promotes oligodendroglial cell maturation in a cuprizone-induced demyelination model

Demyelination arrest and remyelination induced by glatiramer acetate treatment of experimental autoimmune encephalomyelitis

The capacity of glatiramer acetate (GA, Copaxone) to affect the demyelination process and/or lead to remyelinated in mice inflicted by chronic EAE is explored using both scanning electron microscopy and immunohistological methods.

The mechanism of action of glatiramer acetate in multiple sclerosis and beyond.

Remyelination In Multiple Sclerosis

  • D. Chari
  • Biology
    International Review of Neurobiology
  • 2007

Biology of oligodendrocyte and myelin in the mammalian central nervous system.

This review deals with the recent progress related to the origin and differentiation of the oligodendrocytes, their relationships to other neural cells, and functional neuroglial interactions under physiological conditions and in demyelinating diseases.

A functional role for EGFR signaling in myelination and remyelination

It is shown that 2′,3′-cyclic nucleotide 3′-phosphodiesterase (CNP) promoter–driven overexpression of human EGFR (hEGFR) accelerated remyelination and functional recovery following focal demyelinations of mouse corpus callosum and EGFR targeting holds promise for enhancing oligodendrocyte regeneration and myelin repair.

Expression of viral and myelin gene transcripts in a murine CNS demyelinating disease caused by a coronavirus

The histological features of the demyelinating disease were correlated with the spatial and temporal distribution of viral transcripts and the expression of oligodendrocyte‐specific genes in the spinal cord of diseased mice, and increased expression of myelin gene transcripts occurred in a synchronized manner and with a cellular distribution reminiscent of that seen in developmental myelination.